Cited by

• Unfolded protein response inducers tunicamycin and dithiothreitol promote myeloma cell differentiation mediated by XBP-1.

  Jiang H, Zou J, Zhang H, Fu W, Zeng T, Huang H, Zhou F, Hou J. Jiang H, et al. Clin Exp Med. 2015 Feb;15(1):85-96. doi: 10.1007/s10238-013-0269-y. Epub 2013 Dec 20. Clin Exp Med. 2015. PMID: 24356728
• Presenting signs and symptoms in multiple myeloma: high percentages of stage III among patients without apparent myeloma-associated symptoms.

  Ong F, Hermans J, Noordijk EM, Wijermans PW, Kluin-Nelemans JC. Ong F, et al. Ann Hematol. 1995 Mar;70(3):149-52. doi: 10.1007/BF01682035. Ann Hematol. 1995. PMID: 7718643
• Effects of the glucolipid synthase inhibitor, P4, on functional and phenotypic parameters of murine myeloma cells.

  Manning LS, Radin NS. Manning LS, et al. Br J Cancer. 1999 Nov;81(6):952-8. doi: 10.1038/sj.bjc.6690792. Br J Cancer. 1999. PMID: 10576650 Free PMC article.
• A prognostic index for multiple myeloma.

  Grignani G, Gobbi PG, Formisano R, Pieresca C, Ucci G, Brugnatelli S, Riccardi A, Ascari E. Grignani G, et al. Br J Cancer. 1996 May;73(9):1101-7. doi: 10.1038/bjc.1996.212. Br J Cancer. 1996. PMID: 8624271 Free PMC article. Clinical Trial.
• The normal counterpart of IgD myeloma cells in germinal center displays extensively mutated IgVH gene, Cmu-Cdelta switch, and lambda light chain expression.

  Arpin C, de Bouteiller O, Razanajaona D, Fugier-Vivier I, Brière F, Banchereau J, Lebecque S, Liu YJ. Arpin C, et al. J Exp Med. 1998 Apr 20;187(8):1169-78. doi: 10.1084/jem.187.8.1169. J Exp Med. 1998. PMID: 9547329 Free PMC article.